Shaaban, Abeer M. http://orcid.org/0000-0001-5784-8705
Hilton, Bridget
Clements, Karen http://orcid.org/0000-0003-0113-4409
Dodwell, David http://orcid.org/0000-0001-8787-4904
Sharma, Nisha
Kirwan, Cliona
Sawyer, Elinor http://orcid.org/0000-0001-8285-4111
Maxwell, Anthony http://orcid.org/0000-0001-8344-4958
Wallis, Matthew
Stobart, Hilary
Mylvaganam, Senthurun
Litherland, Janet
Brace-McDonnell, Samantha
Dulson-Cox, Joanne
Kearins, Olive
Provenzano, Elena
Ellis, Ian O. http://orcid.org/0000-0001-5292-8474
Pinder, Sarah E. http://orcid.org/0000-0003-4167-8910
Thompson, Alastair M.
Funding for this research was provided by:
Cancer Research UK (C17422/A25154, C38317/A24043, C38317/A24043, C38317/A24043, C38317/A24043)
Article History
Received: 26 March 2022
Revised: 30 August 2022
Accepted: 5 September 2022
First Online: 12 October 2022
Competing interests
: The authors declare no competing interests.
: Ethics Committee approval was not required for this study, originally conducted under the NHS Cancer Screening Programme’s application to the Patient Information Advisory Group (PIAG). More recently, the study has been permitted to process personally identifiable data without consent under Regulation 5 of Statutory Instrument 2002 No. 1438: The Health Service (Control of Patient Information) Regulations 2002 (15/CAG/0207) in line with the following clause: “quality assuring screening services to ensure they are effective and safe, and that any incidents are investigated and managed appropriately”. This statutory exemption to common law permits Public Health England to process personally identifiable data for activities it is ‘responsible and accountable to the Secretary of State for Health for’, as part of its core remit for population screening.
: All authors gave consent for publication.